Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000461670 | SCV000554712 | benign | Ehlers-Danlos syndrome, type 4 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001178581 | SCV000738398 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001178581 | SCV001343057 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001538705 | SCV001756388 | likely benign | not provided | 2021-01-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004533207 | SCV004709322 | likely benign | COL3A1-related disorder | 2021-08-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000461670 | SCV004827558 | likely benign | Ehlers-Danlos syndrome, type 4 | 2024-01-03 | criteria provided, single submitter | clinical testing |